RZ
Reinsurance Group of America, Incorporated
RZB · NYSE
$25.34 +0.00% (+$0.00)
Market Cap $12.8B
P/E Ratio -
Div. Yield 5.67%
ROE 3.67%
Bulios Fair Price
$13.4
47.1% downside
Current Price
$25.34
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RZB is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/B 0.98x
P/S 1.12x
P/FFO N/A
Growth
60 /100
Stable Book val. growth 14.15%
EPS growth 28.66%
Rev. growth 8.36%
Profitability
54 /100
Moderate Op. margin 49.04%
Net margin 3.81%
FCF margin N/A
Quality
20 /100
Poor Asset turnover 0.07x
ROE 3.67%
ROA 0.29%
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
66 /100
Moderate EPS volatility 46.25%
Beta 0.52x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RZB
Online
Sector
Financial Services
Industry
Insurance - Life
CEO
Tony Cheng
Employees
4,300
Headquarters
Chesterfield